X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-24-2024-1488.pdf
https://www.fiercepharma.com/manufacturing/amneal-pulls-four-lots-antibiotic-vancomycin-due-potentially-overfilled-extra-potent
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/amneal-pharmaceuticals-llc-issues-nationwide-voluntary-recall-vancomycin-hydrochloride-oral-solution
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-7-2024-67267.pdf
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/leiters-health-issues-voluntary-nationwide-recall-vancomycin-iv-bags-phenylephrine-iv-bags-and
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-1-2023-13847.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-25-2023-66768.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-6-2023-36272.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-9-2023-9584.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217401
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-31-2023-56013.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-24-2023-89772.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=11202310416
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nppa-revises-ceiling-prices-of-128-formulations/articleshow/97033906.cms
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hospira-inc-issues-voluntary-nationwide-recall-one-lot-vancomycin-hydrochloride-injection-usp#:~:text=Vancomycin%20Injection-,Company%20Announcement,observed%20in%20a%20single%20vial.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214913
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-9-2022-56129.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215195
https://www.newswise.com/articles/a-new-way-to-control-pain-after-knee-replacement-surgery
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215196
https://www.fiercebiotech.com/biotech/summit-will-take-scenic-route-fda-mountain-after-c-diff-convo-regulator
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216591
https://www.fiercebiotech.com/biotech/summit-carves-out-path-forward-after-c-diff-failure-remains-committed-lead-asset
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-2-2022-1643778781.pdf
https://www.europeanpharmaceuticalreview.com/article/167178/microneedle-patch-with-precise-vancomycin-drug-dose-against-mrsa-skin-infections/
https://endpts.com/billionaire-bob-duggans-new-antibiotic-play-fails-a-phase-iii-trial-and-investors-arent-happy/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-15-2021-1639544435.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215821
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-13-2021-1634124785.pdf
https://www.pharmacompass.com/pdf/news/azurity-pharmaceuticals-issues-voluntary-nationwide-recall-of-one-lot-of-firvanq-1631178888.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-16-2020-1600259824.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203300
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-firvanq-kit-208910-vancomycin-hydrochloridetablets-5-mg-and-10-mg-1594796971.pdf
http://portal.anvisa.gov.br/informacoes-tecnicas13/-/asset_publisher/WvKKx2fhdjM2/content/inclusao-de-nova-reacao-adversa-na-bula-do-medicamento-vancocina-cp-cloridrato-de-vancomicina-/33868?p_p_auth=1HLVIl0c&inheritRedirect=false&redirect=http%3A%2F%2Fportal.anvisa.gov.br%2Finformacoes-tecnicas13%3Fp_p_auth%3D1HLVIl0c%26p_p_id%3D101_INSTANCE_WvKKx2fhdjM2%26p_p_lifecycle%3D0%26p_p_state%3Dnormal%26p_p_mode%3Dview%26p_p_col_id%3D_118_INSTANCE_EikhC3EOkiIn__column-1%26p_p_col_pos%3D1%26p_p_col_count%3D3
https://www.hhs.gov/about/news/2020/05/19/hhs-industry-partners-expand-us-based-pharmaceutical-manufacturing-covid-19-response.html
https://endpts.com/fda-grants-breakthrough-status-to-antibiotic-alternative-as-contrafect-rushes-to-join-fight-against-superbug/
https://www.biopharmadive.com/news/after-fanfare-civica-rx-delivers-first-drugs/564206/
https://www.businesswire.com/news/home/20190912005834/en/Crestone-Boulder-Secures-NIH-Funding-Phase-2/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==
http://www.pmlive.com/pharma_news/basilea_moves_closer_to_us_filing_of_novel_antibiotic_1296529
https://www.biospace.com/article/newly-branded-azurity-wins-fda-approval-for-liquid-form-of-amlodipine/
https://www.pharmacompass.com/pdf/news/imprimis-njof-llc-receives-fda-warning-letter-1562735073.pdf
https://www.in-pharmatechnologist.com/Article/2019/07/02/Xellia-moves-production-of-anti-infectives-to-its-distribution-hub
https://www.biospace.com/article/research-roundup-deeper-understanding-of-alzheimer-s-and-more/
https://www.prnewswire.com/news-releases/ani-pharmaceuticals-announces-approval-of-vancomycin-hydrochloride-for-oral-solution-usp-250mg5ml-300872102.html
https://www.fiercepharma.com/pharma-asia/china-s-fosun-rallies-support-for-a-joint-bid-for-bayer-s-animal-health-unit-report
Market Place
Share 
